Article
The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 May 2011
Salaverria Itziar, Siebert Reiner
Abstract excerpt
It has long been recognized that the border between classical Burkitt's lymphoma (BL) and classical diffuse large B-cell lymphoma (DLBCL) is hard to determine. Instead, both classical lymphoma entities seem to be the extreme ends of a spectrum of diseases that contains a group of lymphomas characterized predominately by the fact that they are hard to assign to the one or the other group. This gray zone has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
